Edition:
United Kingdom

Athenex Announces Chinese FDA Allowance Of Investigational New Drug Application Of Oraxol To Begin Clinical Trials


Monday, 8 Jan 2018 

Jan 8 (Reuters) - Athenex Inc ::ATHENEX ANNOUNCES CHINESE FDA ALLOWANCE OF INVESTIGATIONAL NEW DRUG APPLICATION OF ORAXOL TO BEGIN CLINICAL TRIALS.ATHENEX INC - ACCEPTANCE OF ORAXOL IND BY CHINESE FDA ALLOWS ATHENEX TO COMMENCE A CLINICAL TRIAL PROGRAM FOR ORAXOL IN CHINA IN 2018. 

Related Company News

Company Quote

11.06
-0.2 -1.78%
9:00pm BST